mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.093 |
0.08 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.08 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.08 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.08 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.099 |
0.09 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |